Meeting Details

The 47th Annual General Meeting will be held on Monday, August 10, 2026 at 3:00 PM (IST) through Video Conferencing (VC)/Other Audio-Visual Means (OAVM).

Business Items

Ordinary Business:

1. Item No. 1: To receive, consider and adopt the Audited Financial Statements of the Company for the financial year ended March 31, 2026 and the Reports of the Board of Directors and Auditors thereon.

2. Item No. 2: To declare Dividend of ₹36 per share on equity shares for the financial year 2025-26.

3. Item No. 3: To appoint a Director in place of Ms. Bhavana Agrawal (DIN: 10485441) who retires by rotation, and being eligible, offers herself for re-appointment.

Special Business:

4. Item No. 4: Appointment of Statutory Auditors - To appoint M/s. BSR & Co. LLP, Chartered Accountants (Firm Registration No. 101248W/W-100022) as Statutory Auditors for a term of 5 consecutive years from conclusion of 47th AGM till conclusion of 52nd AGM in 2031. Remuneration to be approved by Board of Directors.

5. Item No. 5: Re-appointment of Ms. Shilpa Divekar Nirula (DIN: 06619353) as an Independent Director for a second term of 5 consecutive years from December 29, 2026 to December 28, 2031.

Key Financial Information

  • Proposed dividend: ₹36 per equity share for FY 2025-26
  • Record date for dividend: July 31, 2026
  • Proposed auditor fee for FY 2026-27: Not exceeding ₹80 lakhs for standalone financial statements and other audit engagements, excluding taxes and out-of-pocket expenses

Voting Information

  • Remote e-voting period: August 6, 2026 (9:00 AM IST) to August 9, 2026 (5:00 PM IST)
  • Cut-off date for voting rights: August 3, 2026
  • E-voting service provider: National Securities Depository Limited (NSDL)
  • Scrutinizer: Mr. Vijayakrishna K.T., Practising Company Secretary (Membership No. FCS 1788)

Auditor Transition

M/s. Price Waterhouse and Co. Chartered Accountants LLP (Firm Registration No. 304026E/E-300009) will complete their two consecutive terms aggregating ten years upon conclusion of the 47th AGM.

Director Information

  • Ms. Shilpa Divekar Nirula currently serves as Chairperson of the Board and Member of Audit Committee, Nomination and Remuneration Committee, and Stakeholders' Relationship Committee
  • Ms. Bhavana Agrawal is retiring by rotation
  • Both directors hold nil shares in the company

Document Availability

The Notice and Annual Report for FY 2025-26 are available on the company website (www.astrazeneca.com/india) and stock exchange websites (BSE and NSE).

Additional Information

  • Dividend will be processed only in electronic mode
  • Members must update KYC details for dividend receipt
  • Unclaimed dividends for seven years will be transferred to Investor Education and Protection Fund (IEPF)
  • Members can attend AGM through VC/OAVM facility provided by NSDL